Business
Launch of brain health study with Oura
Cambridge Cognition Holdings plc has announced a significant collaboration with Oura, a leading smart ring manufacturer, to launch a large-scale brain health study. This IRB-approved initiative will integrate Cambridge Cognition's CANTAB Pathway™ digital cognitive assessments, specifically CANTAB One and CANTAB Insight, with Oura's continuous physiological data from up to 45,000 participants throughout 2026. The study aims to explore the relationship between everyday patterns in sleep, stress, activity, and cognitive function, with the insights expected to inform future product development and scalable brain health applications, extending the reach of Cambridge Cognition's technology beyond traditional clinical settings. Disclaimer*
About this update from Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings plc ("Cambridge Cognition", the "Company" or the "Group") Cambridge Cognition and Oura launch large-scale brain health study integrating cognition with wearable sleep and physiological data Cambridge, UK, 28 May 2026: Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces a collaboration with ŌURA, maker of the world's leading smart ring, on a new institutional review board (IRB)-approved brain health study. Conducted through Oura Labs, an experimental innovation platform within the Oura App, the study pairs Cambridge Cognition's scientifically validated digital cognitive assessments with Oura's continuous physiological data. Rather than focusing only on diagnosed disease, this work explores how everyday patterns in rest, stress, and behaviour may relate to cognitive function and performance over time. Oura has established one of the world's leading consumer health platforms, with sensing technology spanning sleep, activity, stress, cardiovascular and metabolic health and more, alongside partnerships with more than 1,200 leading organisations across health, wellness, and commercial brands. Cambridge Cognition's scientifically validated digital cognitive assessments from CANTAB Pathway™ have been integrated into the Oura platform as short in-app tasks, specifically CANTAB One and CANTAB Insight. As part of this large-scale remote observational research programme running through 2026, up to 45,000 participating Oura members will complete these brief assessments alongside continuous monitoring of their sleep, activity, stress and physiological measurements captured by Oura Ring. The study is intended to explore relationships between behavioural, biometric and cognitive measures over time, helping advance understanding of how factors such as sleep, recovery and activity may influence brain health and cognition. The programme is also designed to assess user engagement with consumer-integrated cognitive assessments alongside wearable-derived and self-reported health data. Insights generated from these combined datasets are expected to help inform future product development and scalable brain health applications. The collaboration builds on ...
View stock analysis, news, and events for Cambridge Cognition Holdings Plc